SCPH icon

scPharmaceuticals
SCPH

Overview Fund Activity

33 hedge funds and large institutions have $80M invested in scPharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
10
Reduced
9
Closed
3
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$19K

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$6.89M
2
WVP
2
Worth Venture Partners
New Jersey
$1.67M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$485K
4
TNB
4
Thomasville National Bank
Georgia
$75K
5
IIA
5
IPG Investment Advisors
California
$72K

Top Sellers

1
JGC
1
J. Goldman & Co
New York
$1.86M
2
RCM
2
RA Capital Management
Massachusetts
$13.5M
3
E
3
Ergoteles
New York
$0
4
HF
4
HRT Financial
New York
$0
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$411K
Name Holding Trade Value Shares
Change 		Shares
Change %
Osaic Holdings
26
Osaic Holdings
Arizona
$20K +$256 +50 +1%
UBS Group
27
UBS Group
Switzerland
$11K +$6.88K +1,410 +167%
Bank of America
28
Bank of America
North Carolina
$6K +$92 +18 +2%
Simplex Trading
29
Simplex Trading
Illinois
$2K +$2K +539 New
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$1.92K +$1.39K +277 +261%
E
31
Ergoteles
New York
– -$180K -27,116 Closed
HF
32
HRT Financial
New York
– -$107K -16,189 Closed
Barclays
33
Barclays
United Kingdom
– -$5K -814 Closed
1
2